@hydromedspa's subcutaneous TRT claims, fact-checked
Quick answer
Subcutaneous testosterone cypionate or enanthate injection is an established delivery method for hypogonadism management, with clinical evidence supporting comparable or superior pharmacokinetic stability compared to intramuscular administration in some patient populations. Site selection, needle gauge, and injection volume are all clinically relevant variables that depend on individual patient body composition and prescribed dose. Patients should receive injection training directly from their prescribing provider rather than relying on general social media guidance.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @hydromedspa actually say?
Dr. Travis Jeffers, presenting as a clinician at a med spa, walked through subcutaneous testosterone injection technique in about a minute. His core points: the abdomen is the go-to site for most guys, volume matters when choosing a location, and a 30-gauge half-inch needle going straight in is his preferred approach. He added that longer needles may require a 45-degree angle to avoid going intramuscular.
He also mentioned alternatives including "the flanks," "hips area," and "back of the arm" as viable sites, and advised staying away from the belly button. Nothing here was reckless. This reads like practical clinical guidance, not hype. But there are a few things worth examining more carefully before you take this as settled protocol.
Does the science back this up?
Mostly, yes. Subcutaneous testosterone administration is well-documented and increasingly used in clinical practice. A 2012 study by Olsson et al. in the Journal of Sexual Medicine confirmed that subcutaneous testosterone cypionate produced stable serum levels with good tolerability. A later analysis by Spratt et al. (2017, Journal of Clinical Endocrinology and Metabolism) found subcutaneous delivery produced less peak-to-trough variability than intramuscular in some patients.
The abdominal region is the most commonly recommended site in clinical literature, largely because most patients have accessible subcutaneous fat there and it allows for consistent self-injection. The volume guidance he gives is also supported by practice. Subcutaneous injections are generally limited to 1 mL or less per site to minimize discomfort and absorption issues, which aligns with what he said about smaller volumes giving you more flexibility on site selection.
What did they get wrong (or right)?
His needle guidance is mostly right, but slightly oversimplified. A 30-gauge half-inch needle going straight in works well for patients with adequate subcutaneous fat depth, but it is not universally appropriate. Lean patients with minimal abdominal fat can inadvertently hit muscle with a straight-in technique using even a half-inch needle, depending on body composition. He does not mention this caveat.
His claim that a longer needle "going straight in" would require a 45-degree angle to "stay in the subcutaneous tissues" is accurate in direction but the explanation is a bit muddled. The 45-degree angle reduces effective needle depth, which is the actual reason it is used, not just to stay out of muscle but to control depth relative to fat thickness. That is a minor technical imprecision, not a dangerous error.
He also uses the phrase "simultaneous" when he clearly meant "subcutaneous." That is likely a verbal slip, but worth noting since this video reaches tens of thousands of people learning injection technique.
What should you actually know?
Subcutaneous TRT is a legitimate and increasingly preferred route for many patients. It is not fringe or experimental. If you are on a supervised TRT program, your prescribing clinician should walk you through site selection, needle size, and injection volume based on your specific body composition, not a one-size-fits-all protocol from a short video.
A few things this video does not cover that matter in practice:
- Rotating injection sites is important to reduce localized lipohypertrophy, a real risk with repeated subcutaneous injections in the same spot.
- Subcutaneous absorption rates can vary between sites. The abdomen tends to have faster absorption than the flank or posterior arm, which can affect your testosterone curve.
- Patients on higher-volume protocols, anything over 0.5 mL per injection, may need to split doses across multiple sites, not just pick a larger fat pocket.
- Skin prep, angle confirmation, and aspiration practices vary by clinical setting. Follow your provider's specific guidance.
Nothing in this video should replace a conversation with the clinician managing your TRT. It is useful general context, not a substitute for individualized instruction.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @hydromedspa's subcutaneous TRT claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@hydromedspa's subcutaneous TRT claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Subcutaneous testosterone cypionate or enanthate injection is an established delivery method for hypogonadism management, with clinical evidence supporting comparable or superior pharmacokinetic stability compared to intramuscular administration in some patient populations.
FormBlends verdict
Subcutaneous testosterone cypionate or enanthate injection is an established delivery method for hypogonadism management, with clinical evidence supporting comparable or superior pharmacokinetic stability compared to intramuscular administration in some patient populations. Site selection, needle gauge, and injection volume are all clinically relevant variables that depend on individual patient body composition and prescribed dose. Patients should receive injection training directly from their prescribing provider rather than relying on general social media guidance.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Subcutaneous testosterone cypionate or enanthate injection is an established delivery method for hypogonadism management, with clinical evidence supporting comparable or superior pharmacokinetic stability compared to intramuscular administration in some patient populations. Site selection, needle gauge, and injection volume are all clinically relevant variables that depend on individual patient body composition and prescribed dose. Patients should receive injection training directly from their prescribing provider rather than relying on general social media guidance.
- Subcutaneous testosterone delivery is supported by evidence: Spratt et al. (2017, JCEM) found it may produce less peak-to-trough variability than intramuscular injection in some patients.
- Standard subcutaneous injection volume limits are approximately 1 mL per site. Higher volumes may require splitting across multiple locations, not just selecting a larger fat area.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Subcutaneous testosterone delivery is supported by evidence: Spratt et al. (2017, JCEM) found it may produce less peak-to-trough variability than intramuscular injection in some patients.
- Standard subcutaneous injection volume limits are approximately 1 mL per site. Higher volumes may require splitting across multiple locations, not just selecting a larger fat area.
- A 30-gauge half-inch needle used straight in is appropriate for average body composition, but lean patients with low abdominal fat may still reach muscle tissue with this technique.
- Repeated injections at the same site can cause lipohypertrophy, a localized fat tissue change that alters absorption. Rotating sites is a clinical recommendation, not optional.
- Absorption rates vary by injection site. The abdomen generally absorbs faster than the posterior arm or flank, which can affect your testosterone level curve between doses.
- The video contains a verbal slip using 'simultaneous' instead of 'subcutaneous.' Minor, but this video has over 37,000 views and is being used as educational content.
- No social media video replaces individualized injection training from your prescribing provider, particularly regarding site selection for your specific body composition and dose volume.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
HydroMedSpa · TikTok creator
37.2K views on this video
Subcutaneous TRT is becoming the new standard. It’s not for everyone but most find it convenient and easy. #functionalmedicine #trt #menshealth #hormones #testosterone
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by HydroMedSpa, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.